small molecule

AMLODIPINE BESYLATE AND VALSARTAN

AMLODIPINE BESYLATE; VALSARTAN

Loss of exclusivity—loss of exclusivity

CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand name	AMLODIPINE BESYLATE AND VALSARTAN
Active ingredient	AMLODIPINE BESYLATE; VALSARTAN
Strength	EQ 5MG BASE;160MG
Dosage form	TABLET
Route	ORAL
Modality	Small molecule
FDA approval	March 2015
Marketing status	DISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.